Key Takeaways In a 2025 study, roughly 10% weight loss on a GLP-1 drug raised the share of men with normal total and free testosterone from 53% to 77% with no hormone therapy given
The results showed that activation of the GSK3-Drp1 cascade is dysregulated in the RV of rats subjected to PAB surgery, as evidenced by decreased phosphorylation of GSK3 at Ser9 (GSK3 S9), elevated phosphorylation of Drp1 at Ser616 (Drp1 S616), and decreased phosphorylation of Drp1 at Ser637 (Drp1 S637) (Fig
Initial protocols commonly run six to twelve weeks, with longer courses for complex or chronic cases and maintenance schedules afterward where appropriate
In Alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial
Pancreatic hormones & antidiabetic drugs